This study demonstrates that beta-arrestins mediate the endocytosis of PAR2 and support their role in the uncoupling of irreversibly activated proteinase-activated receptors.
No takes yet. Share an insight, caveat, or question.
Supports beta-arrestin mediation of PAR2 endocytosis in experimental systems; leaves open clinical relevance in protease-driven cardiovascular disease.
Déry et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: